Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

8.6%

170 terminated/withdrawn out of 1974 trials

Success Rate

87.9%

+1.4% vs industry average

Late-Stage Pipeline

11%

211 trials in Phase 3/4

Results Transparency

48%

591 of 1239 completed trials have results

Key Signals

233 recruiting591 with results130 terminated40 withdrawn

Enrollment Performance

Analytics

N/A

1029(60.9%)

Phase 2

279(16.5%)

Phase 1

159(9.4%)

Phase 4

127(7.5%)

Phase 3

84(5.0%)

Early Phase 1

13(0.8%)

1691Total

N/A(1029)

Phase 2(279)

Phase 1(159)

Phase 4(127)

+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (1974)

Showing 20 of 1974 trials

NCT07266077Not ApplicableRecruiting

Influence Of A Slope Adaptive Foot On Participation Of Veterans With Lower-Limb Amputations

Role: collaborator

NCT07336238Phase 2Active Not Recruiting

Group Retreat Psilocybin Therapy for the Treatment of Anxiety and Depression in Patients With Metastatic Solid Tumors or Incurable Hematologic Malignancies

Role: lead

NCT06214910Not ApplicableCompleted

ThiPhiSA: New Pathways to Prevention From Community TB Screening in South Africa

Role: lead

NCT06513949Phase 2Recruiting

Anti-CD14 Treatment With IC14 in Hospitalized ARDS Patients

Role: collaborator

NCT07731789Phase 2Not Yet Recruiting

Tafasitamab and Rituximab for the Treatment of Newly Diagnosed Follicular Lymphoma

Role: lead

NCT07731802Phase 4Not Yet Recruiting

Finasteride and Cutibacterium

Role: lead

NCT05242965Phase 2Recruiting

A Multiple Antigen Vaccine (STEMVAC) for the Treatment of Patients With Stage IV Non-Small Cell Lung Cancer

Role: lead

NCT04557748Completed

LURN: Urinary Urgency Phenotyping Protocol

Role: collaborator

NCT07390084Not ApplicableRecruiting

Exploring the Decision to Drink (More) Alcohol Following Manipulations of Stress and Social Context

Role: lead

NCT07725679Not ApplicableNot Yet Recruiting

A Hybrid Effectiveness-Implementation Trial of Urine Point-of-Care Assay to Increase PrEP Adherence Among Women in Kenya

Role: lead

NCT06508515Not ApplicableCompleted

Iterative Redesign of a Multifaceted Implementation Strategy for a School-based Behavioral Skills Intervention (RUBI)

Role: lead

NCT07573241Not ApplicableRecruiting

Single Arm Trial Identifying Barriers and Facilitators to Mindfulness Practice

Role: lead

NCT07723599Not Yet Recruiting

Combating Age-related Failure of Myelination in Multiple Sclerosis: An Exploratory Study

Role: lead

NCT05455658Phase 2Active Not Recruiting

STEMVAC in Patients With Early Stage Triple Negative Breast Cancer

Role: lead

NCT07721259Phase 2Not Yet Recruiting

A Vaccine (STEMVAC) for Improving Survival in Patients With Triple-Negative Breast Cancer and Moderate or Extensive Residual Cancer Burden

Role: lead

NCT07076043Phase 4Recruiting

Multi-product PrEP Delivery to Young Women Seeking Reproductive Health Services and Coverage of HIV Prevention

Role: collaborator

NCT07718971Enrolling By Invitation

UW ISeqU: Clinical Impact of Whole-genome Sequencing in Adults

Role: lead

NCT03873259Not ApplicableRecruiting

Intraoperative Assessment of of Burst Wave Lithotripsy (BWL)

Role: lead

NCT03495011Active Not Recruiting

MRI Characterization of Mammographically Detected DCIS

Role: lead

NCT06039371Phase 2Recruiting

Supraphysiological Androgen to Enhance Treatment Activity in Metastatic Castration-Resistant Prostate Cancer, SPECTRA Study

Role: lead